5/29/20 16:06  | 5/28/20  | PKI | Perkinelmer Inc | MA | Electr | LabEq | Laboratory Analytical Instrum | Barrett Peter | MA | D |  | S.d | -756 | 100.11 | 0 | -8 | -26 | 22 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/19 18:26  | 2/13/19  | PKI | Perkinelmer Inc | MA | Electr | LabEq | Laboratory Analytical Instrum | Barrett Peter | MA | D |  | S.d | -524 | 93.62 | 0 | -6 | -21 | 22 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/14/17 16:07  | 11/13/17  | PKI | Perkinelmer Inc | MA | Electr | LabEq | Laboratory Analytical Instrum | Barrett Peter | MA | D |  | S.d | -503 | 71.07 | 0 | -7 | -27 | 19 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/2/17 16:09  | 6/1/17  | PKI | Perkinelmer Inc | MA | Electr | LabEq | Laboratory Analytical Instrum | Barrett Peter | MA | D |  | S.d | -632 | 63.22 | 0 | -10 | -34 | 19 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/9/06 16:10  | 3/7/06  | ALNY | Alnylam Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Barrett Peter | MA | D |  | S | -360 | 16.51 | 8 | -22 | -80 | 5 | S |  |  |  |  |  |  |  |  | -2 | 1 | -1 | -9 | -16 | 7 | 
3/7/06 16:19  | 3/3/06  | ALNY | Alnylam Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Barrett Peter | MA | D |  | S.m | -4,106 | 16.97 | 8 | -242 | -98 | 6 | S |  |  |  |  |  |  |  |  | 1 | 1 | 5 | -7 | -12 | 8 | 
3/3/06 09:38  | 3/1/06  | ALNY | Alnylam Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Barrett Peter | MA | D |  | S.m | -2,202 | 16.06 | 7 | -137 | -94 | 8 | S |  |  |  |  |  |  |  |  | 6 | 2 | 8 | -9 | -21 | 6 | 
3/1/06 16:26  | 2/27/06  | ALNY | Alnylam Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Barrett Peter | MA | D |  | S.m | -5,406 | 15.83 | 8 | -342 | -97 | 10 | S |  |  |  |  |  |  |  |  | 0 | 0 | 12 | -8 | -23 | 11 | 
2/27/06 17:30  | 2/23/06  | ALNY | Alnylam Pharmaceuticals, Inc. |  | Health | Drug | Pharmaceutical Preparations | Barrett Peter | MA | D |  | S.m | -1,365 | 14.92 | 7 | -92 | -87 | 13 | S |  |  |  |  |  |  |  |  | 2 | 9 | 12 | -7 | -21 | 28 |